Dunbar Pharma in Athlone is launching the API.
A Midlands based pharma company is launching the first plant-derived dronabinol active pharmaceutical ingredient to the UK market.
Dunbar Pharma in Athlone is to offer what it described as the UK’s first plant-derived dronabinol API, made available through the country's regulated ‘Specials pathway.'
Dunbar Pharma’s WaterClear THC™️ is cannabis plant-derived rather than synthetic and is manufactured in Athlone, and produced to pharmaceutical-grade EU GMP standards.
The company has the support of Enterprise Ireland as it expands its manufacturing capabilities and enters regulated pharmaceutical markets across Europe.
Dunbar's CEO, Leah Fletcher says cannabis-based products for medicinal use (CBPMs) are prepared by in a highly specialised process:
Uisce Éireann Faces €8.2m Charge For Shannon Pipeline In Offaly
Arts Council Awards Over €17m In Funding To 220 Recipients Nationwide
Regional Health Forum Chair ‘Shocked’ As Spending Powers Are Curbed
Westmeath Council Approves 74 New Homes
Westmeath Landlord Ordered To Pay €15k In Damages For "Egregious" Actions
Iarnród Éireann Adding Extra Trains For National Ploughing Championships
Ryanair Boss Compares Rival Airlines To Rapists Over High Fares
Phoenix Park To Close For Two Days Ahead Of Donald Trump Visit